Campbell & CO Investment Adviser LLC Axonics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $33,065 - $41,484	-689 Reduced 2.92%	22,918 $1.16 Million
Q1 2023 May 11, 2023	BUY	$52.6 - $67.34 $149,962 - $191,986	2,851 Added 13.74%	23,607 $1.29 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $392,917 - $505,330	6,597 Added 46.59%	20,756 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $535,550 - $721,828	9,240 Added 187.84%	14,159 $997,000
Q2 2022 Aug 09, 2022	BUY	$39.5 - $64.42 $194,300 - $316,881	4,919 New	4,919 $279,000

235

42.8M

73.7K

230K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.45B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.